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Investigation of the co-occurrence of panic and phobic disorders with joint laxity led to the identification of various
forms of interstitial duplications involving human chromosome 15q24-q26 (named “DUP25”) in a Spanish pop-
ulation. DUP25 was observed in 68 of 70 (97%) patients assigned the diagnosis panic disorder/agoraphobia.
DUP25 was also found in 14 of 189 (7%) control individuals. In the present study, we replicated the experimental
conditions described by Grataco`s and colleagues in which fluorescence in situ hybridization was used to examine
metaphase chromosomes of patients with panic disorder/social phobia and of control individuals from a southern
region of the United Kingdom, the primary aim being to determine the prevalence of this chromosomal rearrange-
ment in a geographically and ethnically distinct population. DUP25 was not observed in any of our 16 patients
or 40 control samples or in three previously reported DUP25-positive control (Centre d’Etude du Polymorphisme
Humain) cell lines, indicating a highly significant difference in the frequency of DUP25 between the study by
Grataco`s and colleagues and the present investigation.
Introduction
Grataco`s et al. (2001), published observations on fam-
ilies in which anxiety disorders and joint laxity were
segregating suggesting that a duplication of 15q24-q26
(which those authors called “DUP25”) was associated
with the disorder. The DUP25 occurred in mosaic form
in virtually all patients with an anxiety disorder in the
seven large families studied, and it occurred in three
types: direct telomeric, inverted telomeric, and direct
centromeric. In addition, 70 unrelated patients with an
anxiety disorder were studied, and DUP25 was seen in
no fewer than 68, whereas, among 189 control speci-
mens, DUP25 was seen in only 14. The DUP25-positive
cells were almost always in the majority, their average
proportion among positive individuals being 59%. Fur-
thermore, the overall size of the duplicated segment was
calculated to be in the order of 14–17 Mb, thereby sug-
gesting that it should be visible by conventional mi-
croscopy in good-quality metaphase spreads. The in-
herited mosaicism, together with the absence of
segregation of 15q24-q26 markers with DUP25, led the
authors to suggest that the mechanism of occurrence of
DUP25 must be non-Mendelian.
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These observations are extremely interesting for two
reasons: first, if substantiated in other populations of
patients with anxiety disorders, the findings provide the
first important association between a genetic change and
a common psychiatric disorder; and, second, they de-
scribe a completely new type of genetic mutation—
namely, a large mosaic duplication that occurs in three
different forms, that must arise in mitosis, and that is
not linked to neighboring loci.
We set out to repeat Grataco`s’s study on a geograph-
ically distinct population. We studied 40 control indi-
viduals and 16 patients with anxiety disorders, (ac-
cording to the criteria of the Diagnostic and Statistical
Manual, 4th edition [DSM-IV] [American Psychiatric
Association 1994]) (table 1). We also thought it was
important to have a positive control, and Professor X.
Estivill kindly provided information on three DUP25-
positive control individuals who were studied in the
Barcelona laboratory. We obtained the cell lines cor-
responding to the three members of CEPH families
(Corriell Cell Repositories). The positive control cell
lines were selected because each represented a different
form of the duplication.
Material and Methods
Patient and Control Populations
The patients consisted of a cohort of 16 unrelated
individuals that included 9 women and 7 men, with ages
ranging from 21 to 65 years of age. All patients were
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Table 1
Psychiatric Disorders in the Study Population
Patient
Beighton
Hypermobility Score DSM-IV Diagnosis
1 3 Panic disorder, agoraphobia, social phobia
2 5 Panic disorder, social phobia
3 1 Social phobia
4 1 Social phobia, agoraphobia
5 0 Panic disorder, major depression, agoraphobia
6 0 Panic disorder, agoraphobia, social phobia, general anxiety disorder
7 0 Panic disorder, agoraphobia, social phobia
8 0 Major depressive episodes, agoraphobia
9 0 Panic disorder, general anxiety disorder
10 0 Major depression, panic disorder
11 6 Panic disorder, general anxiety disorder, major depression, panic attacks, general anxiety disorder
12 0 Major depression, panic disorder, agoraphobia
13 5 Depression, panic disorder, agoraphobia
14 3 Depression, social phobia, panic disorder
15 3 Alcohol abuse, depression, agoraphobia, general anxiety disorder
16 3 Major depression, general anxiety disorder, panic disorder, agoraphobia
currently attending the outpatient clinic at the Psychi-
atric Department of the Royal South Hants Hospital and
had a DSM-IV diagnosis of either panic disorder or so-
cial anxiety. The diagnoses were confirmed using the
Mini International Neuropsychiatric Interview (Sheehan
et al. 1998) and either the Liebowitz Social Anxiety Scale
(Liebowitz 1987) or the Hamilton Rating Scale for Anx-
iety (Hamilton 1959). At interview, each patient under-
went the Beighton hypermobility test (results ranged
from 0 to 6) (Beighton 1993) (table 1) and gave a sample
of blood for karyotyping and FISH testing. All patients
gave written informed consent to participate in the study,
and the protocol was approved by the Southampton and
South West Hants Local Research Ethics Committee.
The control population consisted of 40 anonymized
blood samples from unrelated adults referred for cyto-
genetic analysis because of recurrent miscarriages and
were reported to have a normal karyotype. Three cell
lines reported to be positive for the DUP25 (Grataco`s
et al. 2001) were obtained from the Corriell Cell Re-
positories. These were derived from unrelated samples
of the CEPH families.
Conventional Cytogenetic and FISH Slide Preparation
Conventional cytogenetic analyses were performed
using standard procedures, slides for conventional
cytogenetic analysis were GTG-banded using standard
methods, and high-resolution cytogenetic analysis was
reported at a minimum 550-band resolution.
Selection of FISH Probes
The probes selected for FISH were as described by
Grataco`s et al. (2001) (i.e., cosmids c251-3 and t216-1,
located at the centromeric and telomeric ends of the
DUP25 region, respectively; fig. 1). However, because
t216-1 was not available until late in the study, only
c251-3 was used in combination with the pTRA-25 al-
phoid repeat probe for the chromosome 15 centromere
(D15Z3) (Choo et al 1990); the latter was to facilitate
the rapid localization of the 15 homologues in the met-
aphase spreads. In addition, BACs were chosen (Ensembl
Genome Browser) at the centromeric end of DUP25,
RP11-81A1 at 15q25.1 (GenBank accession number
AC015871.4; NT_010356), which maps to D15S989/
AFM333zh1 and contains the BCL2A1 gene, and,
at the telomeric end of DUP25, RP11-285I14 at
15q25.3 (GenBank accession number AC011966.7;
NT_024670), which contains WI-4034 and part of the
NTRK3 gene. Furthermore, BAC RP11-285I14 is in the
same location as cosmid t216-1 (fig. 1).
FISH
Slides for the FISH experiments were prepared as de-
scribed elsewhere (Crolla et al. 1997). DNA samples
extracted and purified from cosmid, BAC probes were
labeled using a standard nick-translation reaction, and
the labeled probe was coprecipitated with Cot-1 DNA
prior to resuspension in a hybridization buffer contain-
ing five parts deionized formamide plus 20% dextran
sulfate, two parts 10# SSCP, and three parts dH2O.
Targets and probe DNAs were denatured simultaneously
on a hot plate for 5 min at 65C and were left overnight
at 37C in a humid atmosphere. After two 5-min strin-
gent washes at 0.4# SSC/0.1% Tween 20 at 75C, fol-
lowed by 2 min in 2# SSC at room temperature, the
indirectly labeled probes were detected with fluoro-
phores (antidigoxigenin-TRITC [tetramethylrhodamine
isothiocyanate]) (Roche) or avidin–fluorescein isothio-
cyanate (Vector Laboratories). The posthybridization
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Figure 1 Physical map of the 15q24-q26 (DUP25) region show-
ing STSs and genes surrounding the BACs and cosmids used as FISH
probes (Grataco`s et al. 2001). The centromeric (CEN) and telomeric
(TEL) ends are indicated, as is the estimated size of the region.
stringency conditions used in the present study are there-
fore equivalent to those previously reported by Grataco`s
et al. (2001 and references therein). Slides were mounted
in Vectashield (Vector Laboratories) antifade solution
containing 4′,6-diamino-2-phenylindole. Cells were ex-
amined using a Zeiss epifluorescence microscope fitted
with an 8300 Chroma filter set, and images were cap-
tured using MacProbe Applied Imaging software.
Results and Discussion
Each patient sample was tested with two sets of FISH
probes: (1) RP11-81A1 (biotin) at the centromeric end
of DUP25 and RP11-285I14 (digoxigenin) at the telo-
meric end; and (2) c251-3 (digoxigenin) at the centro-
meric end of DUP25 and pTRA25 (biotin). pTRA25
(D15Z3) is an alphoid centromere repeat probe that was
used as an internal FISH control, primarily to facilitate
rapid identification of the 15 homologues within the
metaphase spreads.
A minimum of 40 metaphase spreads were scored on
each sample independently by two observers, one of
whom (J.A.C.) is extremely experienced in all aspects
of FISH. There was no evidence of a duplication of
signals in distal 15q that would be indicative of DUP25
in any of the 16 patient samples or in any of the 40
control samples. Because Grataco`s et al. (2001) reported
an average of 59% of examined cells to be DUP25 pos-
itive, we felt it was unnecessary to extend our analyses
to 140 metaphase spreads from each of the patient and
control samples. The absence of any DUP25-positive
patients is significantly different from the results ob-
tained by Grataco`s et al. (2001) ( ;15Pp 1.58# 10
Fisher’s exact test), whereas the result on the control
sample ( ; Fisher’s exact test) is not significantlyPp .062
different from that of Grataco`s et al. (2001) but does
suggest that DUP25, if it occurs, does so with a different
frequency in the two control populations.
The three CEPH cell lines obtained as positive con-
trols for the present study were tested with both sets of
probes. Fifty metaphase spreads were scored for each
set of probes (30 by M.T. and 20 by J.A.C.), and no
evidence of DUP25 was observed. Because it seemed
possible that the duplication might have been selected
against during culture, suspensions of the cell lines in
fixative were sent to the Barcelona laboratory for con-
firmation of our findings. Surprisingly, L. Armengal and
his colleagues, who scored 22–30 metaphase spreads on
each of our cell line suspensions, reported 40%, 15%–
20%, and 45% respectively to be positive for DUP25.
It is difficult to think of any logical scientific or tech-
nical explanation for the differences between the two
laboratories in scoring the positive control cultures.
However, we were unable to detect any DUP25-positive
cells, either in the positive control samples from CEPH
or in our patient or control samples. Furthermore, we
have never had a report of such a duplication in any of
the thousands of diagnostic samples that have been
scored on high-resolution chromosomes in our labo-
ratory. These results make it important that other
groups try to confirm or refute the presence of a poly-
morphic large mosaic duplication involving chromo-
some band 15q25 and to determine its association with
anxiety disorders.
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